MicroRNA-203 inhibits cell proliferation by repressing ΔNp63 expression in human esophageal squamous cell carcinoma

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Yuan, Yang ^a   Zeng, Zhi Yong ^b   Liu, Xiao Hong ^a   Gong, De Jun ^a   Tao, Jing ^a   Cheng, He Zhong ^a   Huang, Sheng Dong ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b NANJING GENERAL HOSPITAL OF NANJING MILITARY COMMAND   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 203; UNCLASSIFIED DRUG; LUCIFERASE; MIRN203 MICRORNA, HUMAN; TP63 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE; CELL POPULATION; CELL PROLIFERATION; CLONOGENIC ASSAY; CONTROLLED STUDY; DELTANP63 GENE; DOWN REGULATION; ENZYME ASSAY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE REPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; ONCOGENE; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN TARGETING; ESOPHAGUS TUMOR; GENETICS; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; WESTERN BLOTTING;

3' UNTRANSLATED REGIONS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUCIFERASES; MICRORNAS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEINS;

EID: 79551622512     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-57     Document Type: Article

References (27)

1. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003, 349:2241-2252. 10.1056/NEJMra035010, 14657432.
2. Li JY. Epidemiology of esophageal cancer in China. Natl Cancer Inst Monogr 1982, 62:113-120.
3. Gamliel Z, Krasna MJ. Multimodality treatment of esophageal cancer. Surg Clin North Am 2005, 85:621-630. 10.1016/j.suc.2005.01.011, 15927656.
4. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29:e45. 10.1093/nar/29.9.e45, 55695, 11328886.
5. Gratas C, Tohma Y, Barnas C, Taniere P, Hainaut P, Ohgaki H. Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer. Cancer Res 1998, 58:2057-2062.
6. Mizushima T, Nakagawa H, Kamberov YG, Wilder EL, Klein PS, Rustgi AK. Wnt-1 but not epidermal growth factor induces beta-catenin/T-cell factor-dependent transcription in esophageal cancer cells. Cancer Res 2002, 62:277-282.
7. Yang L, Leung AC, Ko JM, Lo PH, Tang JC, Srivastava G, Oshimura M, Stanbridge EJ, Daigo Y, Nakamura Y, Tang CM, Lau KW, Law S, Lung ML. Tumor suppressive role of a 2.4 Mb 9q33-q34 critical region and DEC1 in esophageal squamous cell carcinoma. Oncogene 2005, 24:697-705. 10.1038/sj.onc.1208179, 15580306.
8. Ambros V. microRNAs: tiny regulators with great potential. Cell 2001, 107:823-826. 10.1016/S0092-8674(01)00616-X, 11779458.
9. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006, 6:259-269. 10.1038/nrc1840, 16557279.
10. Hobert O. Gene regulation by transcription factors and microRNAs. Science 2008, 319:1785-1786. 10.1126/science.1151651, 18369135.
11. Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004, 303:83-86. 10.1126/science.1091903, 14657504.
12. Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell 2005, 122:6-7. 10.1016/j.cell.2005.06.036, 16009126.
13. Bueno MJ, Perez de Castro I, Gomez de Cedron M, Santos J, Calin GA, Cigudosa JC, Croce CM, Fernandez-Piqueras J, Malumbres M. Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell 2008, 13:496-506. 10.1016/j.ccr.2008.04.018, 18538733.
14. Lena AM, Shalom-Feuerstein R, Rivetti di Val Cervo P, Aberdam D, Knight RA, Melino G, Candi E. miR-203 represses 'stemness' by repressing DeltaNp63. Cell Death Differ 2008, 15:1187-1195. 10.1038/cdd.2008.69, 18483491.
15. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, Liu CG, Calin GA, Croce CM, Harris CC. MicroRNA expression profiles mediated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 2008, 299:425-436. 10.1001/jama.299.4.425, 2614237, 18230780.
16. Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, Inazawa J. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 2010, 31:766-776. 10.1093/carcin/bgp250, 19843643.
17. Moll UM, Slade N. p63 and p73: roles in development and tumor formation. Mol Cancer Res 2004, 2:371-386.
18. Yi R, Poy MN, Stoffel M, Fuchs E. A skin microRNA promotes differentiation by repressing 'stemness'. Nature 2008, 452:225-229. 10.1038/nature06642, 18311128.
19. Feber A, Xi L, Luketich JD, Pennathur A, Landreneau RJ, Wu M, Swanson SJ, Godfrey TE, Litle VR. MicroRNA expression profiles of esophageal cancer. J Thorac Cardiovasc Surg 2008, 135:255-260. 10.1016/j.jtcvs.2007.08.055, 2265073, 18242245.
20. Mathe EA, Nguyen GH, Bowman ED, Zhao Y, Budhu A, Schetter AJ, Braun R, Reimers M, Kumamoto K, Hughes D, Altorki NK, Casson AG, Liu CG, Wang XW, Yanaihara N, Hagiwara N, Dannenberg AJ, Miyashita M, Croce CM, Harris CC. MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin Cancer Res 2009, 15:6192-6200. 10.1158/1078-0432.CCR-09-1467, 2933109, 19789312.
21. Kano M, Seki N, Kikkawa N, Fujimura L, Hoshino I, Akutsu Y, Chiyomaru T, Enokida H, Nakagawa M, Matsubara H. miR-145, miR-133a and miR-133b: Tumor suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer 2010, 127:2804-2814.
22. Hu H, Xia SH, Li AD, Xu X, Cai Y, Han YL, Wei F, Chen BS, Huang XP, Han YS, Zhang JW, Zhang X, Wu M, Wang MR. Elevated expression of p63 protein in human esophageal squamous cell carcinomas. Int J Cancer 2002, 102:580-583. 10.1002/ijc.10739, 12447998.
23. Koike M, Hibi K, Kasai Y, Ito K, Akiyama S, Nakao A. Molecular detection of circulating esophageal squamous cell cancer cells in the peripheral blood. Clin Cancer Res 2002, 8:2879-2882.
24. Folini M, Gandellini P, Longoni N, Profumo V, Callari M, Pennati M, Colecchia M, Supino R, Veneroni S, Salvioni R, Valdagni R, Daidone MG, Zaffaroni N. miR-21: an oncomir on strike in prostate cancer. Mol Cancer 2010, 9:12. 10.1186/1476-4598-9-12, 2823650, 20092645.
25. Barbieri CE, Perez CA, Johnson KN, Ely KA, Billheimer D, Pietenpol JA. IGFBP-3 is a direct target of transcriptional regulation by DeltaNp63alpha in squamous epithelium. Cancer Res 2005, 65:2314-2320. 10.1158/0008-5472.CAN-04-3449, 15781645.
26. Li SD, Zhang JR, Wang YQ, Wan XP. The role of microRNAs in ovarian cancer initiation and progression. J Cell Mol Med 2010, 14:2240-2249. 10.1111/j.1582-4934.2010.01058.x, 20345848.
27. Rocco JW, Leong CO, Kuperwasser N, DeYoung MP, Ellisen LW. p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis. Cancer Cell 2006, 9:45-56. 10.1016/j.ccr.2005.12.013, 16413471.